Stone, P. W., Osen, M. ., Ellis, A. ., Coaker, R. ., & Quint, J. K. (2023). Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019. Int J Chron Obstruct Pulmon Dis, 18, 1565–1574. http://doi.org/10.2147/copd.s411739
J. Quint
First name
J.
Middle name
K.
Last name
Quint
Requena, G. ., Czira, A. ., Banks, V. ., Wood, R. ., Tritton, T. ., Castillo, C. M., … Ismaila, A. S. (2023). Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 1431–1444. http://doi.org/10.2147/copd.s411437
Morgan, A. ., Gupta, R. S., George, P. M., & Quint, J. K. (2023). Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England. BMC Pulm Med, 23, 256. http://doi.org/10.1186/s12890-023-02550-0
Kallis, C. ., Maslova, E. ., Morgan, A. D., Sinha, I. ., Roberts, G. ., van der Valk, R. J. P., … Tran, T. N. (2023). Recent trends in asthma diagnosis, preschool wheeze diagnosis and asthma exacerbations in English children and adolescents: a SABINA Jr study. Thorax. http://doi.org/10.1136/thorax-2022-219757
Raslan, A. S., Quint, J. K., & Cook, S. . (2023). All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD). Int J Chron Obstruct Pulmon Dis, 18, 1207–1218. http://doi.org/10.2147/copd.s407085
Whittaker, H. ., Rothnie, K. J., & Quint, J. K. (2023). Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England. Thorax. http://doi.org/10.1136/thorax-2022-219320
Czira, A. ., Requena, G. ., Banks, V. ., Wood, R. ., Tritton, T. ., Castillo, C. M., … Ismaila, A. S. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 18, 643–659. http://doi.org/10.2147/copd.s405498
Morgan, A. ., Maslova, E. ., Kallis, C. ., Sinha, I. ., Roberts, G. ., Tran, T. N., … Quint, J. K. (2023). Short-acting β(2)-agonists and exacerbations in children with asthma in England: SABINA Junior. ERJ Open Res, 9. http://doi.org/10.1183/23120541.00571-2022
Cook, S. ., Schmedt, N. ., Broughton, J. ., Kalra, P. A., Tomlinson, L. A., & Quint, J. K. (2023). Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink. BMJ Open, 13, e065927. http://doi.org/10.1136/bmjopen-2022-065927
Attar-Zadeh, D. ., Capstick, T. ., Leese, D. ., Arnetorp, S. ., Rapsomaniki, E. ., Da Costa, K. P., … Quint, J. K. (2023). Healthcare costs associated with short-acting β(2)-agonists in asthma: observational UK SABINA study. BJGP Open. http://doi.org/10.3399/bjgpo.2023.0015